The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $65.70

Today's change-0.90 -1.35%
Updated May 22 1:15 PM EDT. Delayed by at least 15 minutes.
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $65.70

Today's change-0.90 -1.35%
Updated May 22 1:15 PM EDT. Delayed by at least 15 minutes.

Seattle Genetics Inc down (U.S.)$0.90

Seattle Genetics Inc is lower today, dropping (U.S.)$0.90 or 1.35% to (U.S.)$65.70. Over the last five days, shares have gained 4.57% and 24.50% year to date. Shares have outperformed the S&P 500 by 52.65% during the last year.

Key company metrics

  • Open(U.S.) $66.82
  • Previous close(U.S.) $66.60
  • High(U.S.) $66.95
  • Low(U.S.) $65.30
  • Bid / Ask(U.S.) $65.57 / (U.S.) $65.70
  • YTD % change+24.50%
  • Volume298,998
  • Average volume (10-day)651,453
  • Average volume (1-month)635,595
  • Average volume (3-month)750,454
  • 52-week range(U.S.) $35.93 to (U.S.) $75.36
  • Beta2.51
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.27
Updated May 22 1:15 PM EDT. Delayed by at least 15 minutes.

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue10910510695
Total other revenue--------
Total revenue10910510695
Gross profit97949585
Total cost of revenue12121110
Total operating expense168161139129
Selling / general / administrative38413533
Research & development1181089386
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-59-56-32-33
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-60-55-32-33
Income after tax-60-55-32-33
Income tax, total--------
Net income-60-55-32-33
Total adjustments to net income--------
Net income before extra. items-60-55-32-33
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-60-55-32-33
Inc. avail. to common incl. extra. items-60-55-32-33
Diluted net income-60-55-32-33
Dilution adjustment--------
Diluted weighted average shares142142141140
Diluted EPS excluding extraordinary itemsvalue per share-0.42-0.39-0.23-0.23
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.42-0.39-0.23-0.23